cardiovascular disorders in the context of non-alcoholic fatty liver disease: a literature review
نویسندگان
چکیده
non-alcoholic fatty liver disease (nafld) is the leading cause of chronic liver disease in the united states and other industrialized countries, and the reported prevalence in the developing countries is also rather high. this disease is associated with a high rate of morbidity and mortality and damage to the other organs. the cardiovascular system is, perhaps, the most vulnerable organ to nafld adverse effects to the extent that most mortality associated with this disease is reportedly from the cardiovascular system rather than from the liver itself. in this article, we review the significant aspects of cardiovascular disorders associated with nafld, including the epidemiology of cardiovascular diseases in nafld patients, factors that interfere in this relationship like hypertension, severity of nafld, and age of the patients, and finally preventive strategies whose employment could significantly improve the outcome.
منابع مشابه
Cardiovascular Disorders in the Context of Non-Alcoholic Fatty Liver Disease: A Literature Review
Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease in the United States and other industrialized countries, and the reported prevalence in the developing countries is also rather high. This disease is associated with a high rate of morbidity and mortality and damage to the other organs. The cardiovascular system is, perhaps, the most vulnerable organ to NAFL...
متن کاملEvaluation of the effects of resveratrol on non-alcoholic fatty liver disease A systematic review study
Introduction: Non-alcoholic fatty liver disease (NAFLD) is a condition in which triglycerides accumulate in liver cells without a history of alcohol consumption. Evidence has shown that auxiliary treatments, including the use of antioxidant compounds, can be effective in improving nonalcoholic fatty liver. Resveratrol is an antioxidant compound that has been shown to be beneficial in some disea...
متن کاملLifestyle in Non-alcoholic Fatty Liver: A Review
Background: The world is now in the process of passing on health to non-diseases chronic, like non-alcoholic fatty liver (NAFLD) is a major cause of changes in the lifestyle of people. This study aims to evaluate the effects of lifestyle on fatty liver disease (NAFLD). Methods: For this critical review, we identified articles by searching original studies and review articles published in peer ...
متن کاملThe Effect of GeriLact on Non-Alcoholic Fatty Liver Disease
Background: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease which is correlated with overweight, obesity, and insulin resistance. Recently, the use of probiotics has been suggested for these patients as they have considerable outcomes. The aim of the present study is to evaluate the effect of GeriLact on patients with NAFLD. Method:</...
متن کاملThe Efficacy of Silymarin and Vitamin E in Non-Alcoholic Fatty Liver Disease: A Clinical Trial
Abstract Objective: Nowadays, lifestyle modification is the best treatment recommended to patients with the nonalcoholic fatty liver disease (NAFLD). The therapeutic effects of vitamin E and silybin on liver functions were documented. The present study was conducted to examine the effect of silymarin and vitamin E on patients with NAFLD. Materials and Methods: From September 2014 to March 201...
متن کاملCardiovascular disease in patients with non-alcoholic fatty liver disease
As it affects almost every third individual in the general population in the Western world, non-alcoholic fatty liver disease (NAFLD) represents the most common cause of chronic liver disease and the most common cause of liver transplantation. Recently, NAFLD has gained much attention in the metabolic field. A continuously increasing amount of evidence suggests that NAFLD is strongly associated...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
the journal of tehran university heart centerجلد ۹، شماره ۱، صفحات ۱-۸
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023